MRVI
Maravai Lifesciences Holdings Inc
7.40$
+3.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.9% | 47.1% | 46.2% | 47.3% | 53.1% | 42.6% | 39.2% | 40.1% | 38.4% | 38.4% | 35.3% | 25.8% | |
| 25.6% | 38.7% | 38.9% | 39.6% | 45.2% | 32.0% | 29.7% | 30.1% | 28.7% | 28.1% | 23.3% | 11.6% | |
| 25.6% | 38.7% | 38.9% | 39.6% | 45.2% | 32.0% | 29.7% | 30.1% | 28.7% | 28.1% | 23.3% | 11.6% | |
| 2.2% | 3.7% | 2.7% | 2.7% | 2.3% | 3.8% | 3.0% | 3.1% | 2.7% | 3.3% | 4.7% | 5.2% | |
| 2.2% | 3.5% | 3.5% | 3.4% | 3.9% | 5.0% | 5.2% | 5.2% | 5.3% | 5.3% | 5.7% | 6.8% | |
| 14.4% | 21.9% | 22.6% | 22.5% | 13.4% | 15.9% | 16.7% | 14.4% | 15.2% | 16.8% | 18.1% | 21.4% | |
| 10.0% | 14.9% | 14.8% | 14.3% | 15.8% | 19.3% | 20.8% | 21.5% | 21.9% | 19.7% | 20.3% | 22.9% | |
| 60.7% | 46.9% | 46.2% | 46.4% | 52.0% | 42.8% | 44.7% | 47.8% | 49.1% | 51.6% | 48.3% | 41.1% | |
| 3.5% | 5.9% | 4.1% | 4.7% | 4.9% | 5.7% | 6.6% | 7.8% | 7.3% | 5.8% | 6.0% | 6.4% | |
| 0.6% | 0.9% | 0.9% | 0.9% | 1.1% | 1.4% | 0.7% | 0.7% | 0.6% | 0.7% | 0.8% | 0.2% | |
| 0.4% | 0.7% | 0.6% | 0.9% | 0.7% | 1.2% | 1.0% | 1.3% | 0.9% | 0.4% | 1.2% | 1.2% | |
| 22.9% | 34.9% | 35.8% | 35.7% | 40.4% | 28.8% | 30.2% | 32.2% | 33.8% | 37.2% | 33.0% | 24.2% | |
| 22.9% | 28.0% | 28.4% | 30.2% | 27.0% | 32.3% | 31.3% | 29.6% | 28.9% | 27.6% | 29.7% | 33.9% | |
| 17.3% | 19.2% | 18.9% | 18.4% | 13.1% | 14.0% | 11.6% | 8.0% | 5.4% | 1.3% | 0.9% | -1.0% | |
| 5.8% | 8.9% | 9.2% | 9.4% | 11.1% | 13.9% | 14.9% | 16.1% | 17.0% | 18.8% | 20.5% | 24.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.